Literature DB >> 20530750

p53 and NF-κB: different strategies for responding to stress lead to a functional antagonism.

Prashanth Ak1, Arnold J Levine.   

Abstract

The p53 transcription factor responds to a variety of intrinsic stresses, such as DNA damage, hypoxia, and even oncogene activation. NF-κB responds to a large number of extrinsic stresses such as cytokine activation and infectious diseases. The p53 tumor suppressor limits the consequences of stress by initiating cell death, senescence, or cell cycle arrest and promotes metabolic patterns in the cell to favor oxidative phosphorylation. NF-κB, the oncogene, promotes cell division, which initiates the innate and adaptive immune responses utilizing large amounts of glucose in aerobic glycolysis, resulting in the synthesis of substrates for cell division. Thus these two transcription factors, both of which have evolved to respond to different types of stress, have adopted opposite strategies and cannot function in the same cell at the same time. On activation of one of these transcription factors, the other is inactivated. This is achieved at several places in the p53 and NF-κB pathways where regulatory proteins act on both p53 and NF-κB with opposite functional consequences. These internodal sites create core regulatory circuits essential for integrating two central pathways in cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530750     DOI: 10.1096/fj.10-160549

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  94 in total

Review 1.  Clinical implications of cellular stress responses.

Authors:  Borut Poljšak; Irina Milisav
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

Review 2.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

3.  Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy.

Authors:  Gipsy Majumdar; Robert J Rooney; I Maria Johnson; Rajendra Raghow
Journal:  Physiol Genomics       Date:  2011-09-27       Impact factor: 3.107

4.  Bisindolylmaleimide alkaloid BMA-155Cl induces autophagy and apoptosis in human hepatocarcinoma HepG-2 cells through the NF-κB p65 pathway.

Authors:  Xiao Sun; Lin Li; Hong-Guang Ma; Pu Sun; Qi-Lin Wang; Ting-Ting Zhang; Yue-Mao Shen; Wei-Ming Zhu; Xia Li
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

5.  Introduction: The Changing Directions of p53 Research.

Authors:  Arnold J Levine
Journal:  Genes Cancer       Date:  2011-04

6.  A new inflammatory role for p53 in human macrophages.

Authors:  Julie M Lowe; Daniel Menendez; Michael B Fessler
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 7.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

8.  Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized (13)C magnetic resonance spectroscopic imaging.

Authors:  Jae Mo Park; Lawrence D Recht; Sonal Josan; Milton Merchant; Taichang Jang; Yi-Fen Yen; Ralph E Hurd; Daniel M Spielman; Dirk Mayer
Journal:  Neuro Oncol       Date:  2013-01-17       Impact factor: 12.300

9.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

10.  IκB kinase β (IKKβ) inhibits p63 isoform γ (TAp63γ) transcriptional activity.

Authors:  Jun-Ming Liao; Yu Zhang; Wenjuan Liao; Sheyla X Zeng; Xiaohua Su; Elsa R Flores; Hua Lu
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.